---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-013237"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T08:35:37.256907+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NextCure Q2 net loss $17.9M; cash $130.6M; Phase 1b data expected Q4 2023

## Summary
- Cash, cash equivalents and marketable securities of $130.6M as of June 30, 2023, down from $159.9M at Dec 31, 2022.
- Net loss of $17.9M for Q2 2023, flat versus Q2 2022; R&D expense $13.4M, G&A $5.7M.
- Phase 1b data for NC410, NC762 update, and NC525 Phase 1a update all expected in Q4 2023.
- Existing cash expected to fund operations into mid-2025.
- NC318 data from Yale Cancer Center to be presented at WCLC in September 2023.

## SEC filing metadata
- accession: 0001558370-23-013237
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000155837023013237/0001558370-23-013237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000155837023013237/nxtc-20230803x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-013237
- JSON: https://secwatch.observer/filing/0001558370-23-013237.json
- Plain text: https://secwatch.observer/filing/0001558370-23-013237.txt

## Key facts
- Earnings Releases
  NextCure, Inc. reported quarter ended June 30, 2023 results: net income Net loss was $17.9 million.
  - Period: quarter ended June 30, 2023
  - Net income: Net loss was $17.9 million
  - Result: reported results
  source text: On August 3, 2023, NextCure, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661059/000155837023013237/0001558370-23-013237-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.